Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
20.86
-0.15 (-0.71%)
At close: May 22, 2026, 4:00 PM EDT
20.56
-0.30 (-1.42%)
After-hours: May 22, 2026, 7:52 PM EDT
Arcutis Biotherapeutics Employees
Arcutis Biotherapeutics had 354 employees as of December 31, 2025. The number of employees increased by 12 or 3.51% compared to the previous year.
Employees
354
Change (1Y)
12
Growth (1Y)
3.51%
Revenue / Employee
$1,174,079
Profits / Employee
-$6,712
Market Cap
2.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 354 | 12 | 3.51% |
| Dec 31, 2024 | 342 | 46 | 15.54% |
| Dec 31, 2023 | 296 | 28 | 10.45% |
| Dec 31, 2022 | 268 | 121 | 82.31% |
| Dec 31, 2021 | 147 | 93 | 172.22% |
| Sep 30, 2021 | 143 | 90 | 169.81% |
| Jun 30, 2021 | 108 | 59 | 120.41% |
| Mar 31, 2021 | 75 | 32 | 74.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 339 |
| Alumis | 227 |
| Structure Therapeutics | 220 |
| Immunome | 177 |
| Disc Medicine | 154 |
| IDEAYA Biosciences | 145 |
| Definium Therapeutics | 106 |
ARQT News
- 16 days ago - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - Arcutis Biotherapeutics price target lowered to $34 from $35 at Morgan Stanley - TheFly
- 18 days ago - Arcutis Biotherapeutics reports Q1 EPS (9c), consensus (6c) - TheFly
- 18 days ago - Arcutis Biotherapeutics backs FY26 revenue view $480M-$495M, consensus $498.07M - TheFly
- 18 days ago - Arcutis Biotherapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 18 days ago - Arcutis Biotherapeutics Earnings release: Q1 2026 - Filings
- 18 days ago - Arcutis Biotherapeutics Quarterly report: Q1 2026 - Filings
- 18 days ago - Arcutis Biotherapeutics Slides: Q1 2026 - Filings